T1	Procedure 303 323	chemotherapy regimen
T2	Procedure-Name 303 323	chemotherapy regimen
E1	Procedure:T1 Name:T2 Temporality:E38
T3	Condition 763 779	pleural effusion
T4	Condition-Name 763 779	pleural effusion
E3	Condition:T3 Name:T4
T5	Procedure 825 841	ascites drainage
T6	Procedure-Name 825 841	ascites drainage
E5	Procedure:T5 Name:T6 Temporality:E54
T7	Condition 747 761	cancer ascites
T8	Condition-Name 747 761	cancer ascites
E7	Condition:T7 Name:T8
T9	Eq-Operator 175 176	≥
A1	Eq-Operator-Value T9 GTEQ
T10	Eq-Operator 384 385	≤
A2	Eq-Operator-Value T10 LTEQ
T11	Eq-Operator 574 580	within
A3	Eq-Operator-Value T11 LTEQ
T12	Eq-Operator 623 624	<
A4	Eq-Operator-Value T12 LT
T13	Eq-Operator 842 848	within
A5	Eq-Operator-Value T13 LTEQ
T14	Eq-Temporal-Unit 387 392	weeks
A6	Eq-Temporal-Unit-Value T14 week
T15	Eq-Temporal-Unit 583 588	weeks
A7	Eq-Temporal-Unit-Value T15 week
T16	Eq-Temporal-Unit 851 857	months
A8	Eq-Temporal-Unit-Value T16 month
T17	Eq-Value 176 177	2
T18	Eq-Value 385 386	8
T19	Eq-Value 581 582	4
T20	Eq-Value 625 626	5
T21	Eq-Value 849 850	2
T22	Eq-Comparison 175 177	≥2
E8	Eq-Comparison:T22 Operator:T9 Value:T17
T23	Eq-Comparison 384 392	≤8 weeks
E9	Eq-Comparison:T23 Operator:T10 Temporal-Unit:T14 Value:T18
T24	Eq-Comparison 574 588	within 4 weeks
E10	Eq-Comparison:T24 Operator:T11 Temporal-Unit:T15 Value:T19
T25	Eq-Comparison 622 649	(< 5 elimination half-lives
E11	Eq-Comparison:T25 Operator:T12 Value:T20 Unit:T67
T26	Eq-Comparison 842 857	within 2 months
E12	Eq-Comparison:T26 Operator:T13 Temporal-Unit:T16 Value:T21
T27	Condition 92 98	cancer
E2	Condition:T27 Name:T28 Severity:T36
T28	Condition-Name 92 98	cancer
T29	Condition 148 154	cancer
E4	Condition:T29 Name:T30
T30	Condition-Name 148 154	cancer
R2	Example-Of Arg1:E4 Arg2:E2	
T33	Modifier 71 91	endometrioid ovarian
E13	Modifier:T33 Modifies:E2
T34	Modifier 61 67	serous
E14	Modifier:T34 Modifies:E2
T35	Or 68 70	or
E15	Or:T35 Arg:E14 Arg2:E13
T36	Severity 50 60	high-grade
A9	Severity-Value T36 severe
T37	Procedure 25 39	Histologically
E16	Procedure:T37 Name:T38
T38	Procedure-Name 25 39	Histologically
R3	Found-By Arg1:E2 Arg2:E16	
T39	Procedure 187 215	platinum-containing regimens
E17	Procedure:T39 Name:T40 Temporality:E18 Minimum-Count:E8
T40	Procedure-Name 187 215	platinum-containing regimens
T41	Eq-Comparison 178 186	previous
E18	Eq-Comparison:T41 Temporal-Period:T42
T42	Eq-Temporal-Period 178 186	previous
A11	Eq-Temporal-Period-Value T42 past
T43	Modifier 288 302	platinum-based
E19	Modifier:T43 Modifies:E1
T44	Condition 221 238	Complete response
E20	Condition:T44 Name:T48
T45	Condition 247 263	partial response
E21	Condition:T45 Name:T50
T46	Condition 240 242	CR
E22	Condition:T46 Name:T49
T47	Condition 265 267	PR
E23	Condition:T47 Name:T51
T48	Condition-Name 221 238	Complete response
T49	Condition-Name 240 242	CR
T50	Condition-Name 247 263	partial response
T51	Condition-Name 265 267	PR
R4	Abbrev-Of Arg1:E22 Arg2:E20	
R5	Abbrev-Of Arg1:E23 Arg2:E21	
T52	Or 244 246	or
E24	Or:T52 Arg:E20 Arg2:E21
R6	Using Arg1:E21 Arg2:E1	
R7	Using Arg1:E20 Arg2:E1	
T53	Procedure 412 420	platinum
E25	Procedure:T53 Name:T54 Temporality:E39
T54	Procedure-Name 412 420	platinum
T55	Procedure 452 461	treatment
E26	Procedure:T55 Temporality:E42
T57	Drug 469 497	poly (ADP-ribose) polymerase
E27	Drug:T57 Name:T58
T58	Drug-Name 469 497	poly (ADP-ribose) polymerase
T59	Drug 499 503	PARP
E28	Drug:T59 Name:T60
T60	Drug-Name 499 503	PARP
R8	Using Arg1:E26 Arg2:E27	
R9	Abbrev-Of Arg1:E28 Arg2:E27	
T63	Drug 699 704	drugs
E30	Drug:T63 
T65	Modifier 668 686	molecular targeted
E31	Modifier:T65 Modifies:E30
T66	Study 657 662	study
E32	Study:T66 Study-Of:E49
T67	Eq-Unit 639 649	half-lives
T68	Procedure 793 801	drainage
E33	Procedure:T68 
T69	Temporal-Connection 858 866	prior to
E34	Temporal-Connection:T69 Arg:E5 Arg2:E56
T70	Drug 877 891	administration
E35	Drug:T70 Temporality:E56
A12	Temporal-Connection-Type-Value E34 before
T31	Modifier 110 128	primary peritoneal
E6	Modifier:T31 
T32	Modifier 133 147	fallopian tube
E36	Modifier:T32 Modifies:T30
T72	Or 129 132	and
E37	Or:T72 Arg:E6 Arg2:E36
T73	Eq-Comparison 283 287	last
E38	Eq-Comparison:T73 Temporal-Recency:T74
T74	Eq-Temporal-Recency 283 287	last
A10	Eq-Temporal-Recency-Value T74 most-recent-time
T75	Eq-Comparison 399 403	last
E39	Eq-Comparison:T75 Temporal-Recency:T76
T76	Eq-Temporal-Recency 399 403	last
A13	Eq-Temporal-Recency-Value T76 most-recent-time
T77	Assertion 359 369	Ability to
E40	Assertion:T77 Asserted:E25
A14	Assertion-Type-Value E40 hypothetical
T78	Temporal-Connection 393 398	after
E41	Temporal-Connection:T78 Arg:E9 Arg2:E39
A15	Temporal-Connection-Type-Value E41 after
T79	Eq-Comparison 446 451	Prior
E42	Eq-Comparison:T79 Temporal-Period:T80
T80	Eq-Temporal-Period 446 451	Prior
A16	Eq-Temporal-Period-Value T80 past
T56	Modifier 505 514	inhibitor
E43	Modifier:T56 Modifies:T58
T81	Study 553 558	study
E44	Study:T81 Study-Of:E29
T82	Other 547 552	other
E45	Other:T82 Is-Other:E44
T61	Procedure 564 573	treatment
E29	Procedure:T61 Temporality:E10
T62	Drug 559 563	drug
E46	Drug:T62 
R1	Using Arg1:E29 Arg2:E46	
T83	Eq-Comparison 602 607	first
E47	Eq-Comparison:T83 Temporal-Recency:T84
T84	Eq-Temporal-Recency 602 607	first
A17	Eq-Temporal-Recency-Value T84 first-time
T85	Temporal-Connection 589 597	prior to
E48	Temporal-Connection:T85 Arg:E10 Arg2:E47
A18	Temporal-Connection-Type-Value E48 before
R10	Equivalent-To Arg1:E11 Arg2:E47	
T86	Drug 663 667	drug
E49	Drug:T86 Temporality:E47
T64	Condition 692 698	cancer
E50	Condition:T64 Name:T87
T87	Condition-Name 692 698	cancer
R11	Treatment-For Arg1:E30 Arg2:E50	
R12	Example-Of Arg1:E30 Arg2:E49	
T88	Assertion 735 743	symptoms
E51	Assertion:T88 Asserted:E7 Asserted2:E3
A19	Assertion-Type-Value E51 possible
T89	Assertion 785 789	need
E52	Assertion:T89 Asserted:E33
A20	Assertion-Type-Value E52 hypothetical
T90	And 781 784	who
E53	And:T90 Arg:E3 Arg2:E52
T91	Eq-Comparison 815 824	undergone
E54	Eq-Comparison:T91 Temporal-Period:T92
T92	Eq-Temporal-Period 815 824	undergone
A21	Eq-Temporal-Period-Value T92 past
T93	Or 803 805	or
E55	Or:T93 Arg:E33 Arg2:E5
T71	Eq-Comparison 871 876	first
E56	Eq-Comparison:T71 Temporal-Recency:T94
T94	Eq-Temporal-Recency 871 876	first
A22	Eq-Temporal-Recency-Value T94 first-time
